The firm typically invests in funding rounds with three participants, with notable sponsors including Novartis Venture Fund, LODH Immunology Fund, and JapanWorks. They tend to secure funding for subsequent rounds from VI Partners AG, SV Health Investors, and Novartis Venture Fund. The fund has had a significant number of successful exits in 2009 and typically invests in deals ranging from $10 to $50 million. InnoVentures focuses on the Internet and healthcare sectors, with ESBATech being one of their notable portfolio startups. They prefer to invest in startups that are 4-5 years old and are Utah's leading provider of venture debt through their management of the UTFC funds. Their portfolio companies are primarily early-stage information technology or service companies seeking growth capital for marketing activities. Many of their clients combine venture debt financing with angel funding or traditional venture capital to minimize dilution for management and outside investors. Some clients seek to increase their valuation before obtaining equity funding, as this has helped attract investors who were initially hesitant due to low sales.